13C-glucose drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| 13C-glucose | associated_with | CO2 | — | 1 |
| glucose | associated_with | 13C-glucose | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. (2016)
- The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| 13c-glucose | drug | 2 | 7 |
| u-13c6 glucose | drug | — | — |
| [u-13c6] glucose | drug | — | — |